Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by KayakerBCon Apr 21, 2022 1:42pm
105 Views
Post# 34621016

RE:trying to understand?

RE:trying to understand?The news first come out after the market closed on i believe a up day to close @.26. Since that time the fierce article followed & the volume has been pretty much zero & not a soul has even hit the ask which has sit below .26 mark since the first NR- can someone help me to understand this without being a sausage or if u must - just need to understand why? Just seems odd - I would of thought a few of the more positive folks would be plucking these off like crazy- at the same time pockets might be filled up regardless of the low SP.

I'll repeat what I said a week ago. Lack of interest is no surprise.  The market doesn't get excited about what might happen somewhere down the road.  The J&J deal is good but for unknown drugs on an unknown time frame.  The Fierce Pharma article doesn't change that.  IMO it will take news of an imminent clinical trial, or possibly a deal with big up-front $$$ or a big milestone payment to generate any excitement.
<< Previous
Bullboard Posts
Next >>